Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 949065, 12 pages
http://dx.doi.org/10.1155/2015/949065
Research Article

Herb-Partitioned Moxibustion Regulates the TLR2/NF-κB Signaling Pathway in a Rat Model of Ulcerative Colitis

1Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China
2Key Laboratory of Acupuncture-Moxibustion and Immunological Effects, Shanghai University of Traditional Chinese Medicine, Shanghai 200030, China

Received 31 December 2014; Accepted 2 June 2015

Academic Editor: Tetsuya Kondo

Copyright © 2015 Xiaomei Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. H. Luo, X. Wang, and K. C. Wu, “Progress in stem cell therapy for inflammatory bowel disease,” Chinese Journal of Gastroenterology, vol. 15, no. 11, pp. 641–645, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Liu, X. F. Li, and L. Tang, “Progress in Toll-like receptors mediated the intestinal immune,” Chinese Journal of Microecology, vol. 21, no. 3, pp. 278–282, 2009. View at Google Scholar
  3. L. A. J. O'Neill, C. E. Bryant, and S. L. Doyle, “Therapeutic targeting of toll-like receptors for infectious and inflammatory diseases and cancer,” Pharmacological Reviews, vol. 61, no. 2, pp. 177–197, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. X. Lin and J. Liu, “TLR4/MyD88/NF-κb signaling pathway and ulcerative colitis,” Chinese Journal of Gastroenterology, vol. 18, no. 4, pp. 244–246, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. X. Liu, Y. W. Ding, and H. Lin, “Expression of TLR2, TLR3, TLR5 and TLR9 in colon of ulcerativecolitis mice,” Chinese Journal of Modern Medicine, vol. 22, no. 22, pp. 19–22, 2012. View at Google Scholar
  6. S. J. Sun, “Progress in Toll-like receptor 2,” Chongqing Medicine, vol. 37, no. 5, pp. 533–535, 2008. View at Google Scholar
  7. Y. J. Fan, J. T. Song, F. H. Pei et al., “Effect of valsartan on neointimal hyperplasia and TLR4 expression in carotid artery of balloon injured rat,” Chinese Journal of Gastroenterology and Hepatology, vol. 23, no. 2, pp. 147–149, 2014. View at Google Scholar
  8. L. Wang, “Clinical research of moxibustion on the treatment of ulcerative colitis,” Chinese Journal of Health Care and Medicine, vol. 12, no. 2, pp. 154–155, 2012. View at Google Scholar
  9. N. Xu, “Toll-like receptors, NF-κB and inflammatory bowel disease,” International Journal of Digestive Diseases, vol. 23, no. 5, pp. 264–267, 2003. View at Google Scholar
  10. H. G. Wu, Z. Huang, H. R. Liu et al., “Experimental study on influence of acupuncture and moxibustion therapy on apoptosis colonic epithelial cells ts of ulcerative colitis,” Zhongguo Zhenjiu, vol. 25, no. 2, pp. 119–122, 2005. View at Google Scholar
  11. Z. Shi, X. P. Ma, H. G. Wu et al., “Rein rasearch on acupuncture regulating cox-2 and IL-1β in colon tissue of rat with ulcerative colitis,” Journal of Jiangxi University of Traditional Chinese Medicine, vol. 16, no. 3, pp. 38–40, 2004. View at Google Scholar
  12. N. Li, X. F. Zhang, and H. Y. Niu, “Expression of TLR2 in colon mucosa of ulcerative colitis,” Chinese Journal of Digestive Endoscopy, vol. 25, no. 10, pp. 535–539, 2008. View at Google Scholar
  13. S. N. Liu, X. F. Lu, N. Sun et al., “Toll-like receptors 2 and 4 and nuclear factor-κB in colonic mucosa of ulcerative colitis: expression and clinical significance,” Journal of Shandong University (Health Sciences), vol. 50, no. 2, pp. 60–63, 2012. View at Google Scholar
  14. Y. P. Liu and Y. Q. Li, “Expression and significance of nuclear factor-κB in ulcerative colitis,” Chinese Journal of Gastroenterology, vol. 11, no. 2, pp. 103–106, 2006. View at Google Scholar
  15. P. Radwan, K. Radwan-Kwiatek, J. Tabarkiewicz, S. Radej, and J. Rolinski, “Enhanced phenotypic and functional maturation of monocyte-derived dendritic cells from patients with active crohn's disease and ulcerative colitis,” Journal of Physiology and Pharmacology, vol. 61, no. 6, pp. 695–703, 2010. View at Google Scholar · View at Scopus
  16. S. Y. Xu, R. L. Bian, and X. Chen, Pharmacology Experiment Methodology, People's Medical Publishing House, Beijing, China, 2002.
  17. Z. R. Li, Experimental Acupuncture Science, China Press of Traditional Chinese Medicine, Beijing, China, 2007.
  18. H. G. Wu, G. Ji, Z. Shi et al., Diagnosis and Treatment of Ulcerative Colitis in Traditional Chinese Medicine, Shanghai Scientific & Technological Publishers, 2009.
  19. S. Watanabe, M. Yamakawa, T. Hiroaki, S. Kawata, and O. Kimura, “Correlation of dendritic cell infiltration with active crypt inflammation in ulcerative colitis,” Clinical Immunology, vol. 122, no. 3, pp. 288–297, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Zhao and F. Gao, “New progress in the pathogenesis of ulcerative colitis,” Progress in Modern Biomedicine, vol. 10, no. 16, pp. 3160–3165, 2010. View at Google Scholar
  21. X. D. Zhao and W. Zhang, “Review on the pathogenesis of ulcerative colitis,” Modern Medicine & Health, vol. 24, no. 10, pp. 1501–1502, 2008. View at Google Scholar
  22. H. Shiroeda, T. Tahara, M. Nakamura et al., “Association between functional promoter polymorphisms of macrophage migration inhibitory factor (MIF) gene and ulcerative colitis in Japan,” Cytokine, vol. 51, no. 2, pp. 173–177, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Liu, Y. Wang, M. Yamakuchi et al., “Upregulation of toll-like receptor 2 gene expression in macrophage response to peptidoglycan and high concentration of lipopolysaccharide is involved in NK-kappaB activation,” Infection and Immunity, vol. 69, no. 5, pp. 2788–2796, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Radwan, K. Radwan-Kwiatek, J. Tabarkiewicz, S. Radej, and J. Rolinski, “Enhanced phenotypic and functional maturation of monocyte-derived dendritic cells from patients with active Crohn's disease and ulcerative colitis,” Journal of Physiology and Pharmacology, vol. 61, no. 6, pp. 695–703, 2010. View at Google Scholar · View at Scopus
  25. J. Bauditz, S. Wedel, and H. Lochs, “Thalidomide reduces tumour necrosis factor-α and interleukin 12 production in patients with chronic active Crohn's disease,” Gut, vol. 50, no. 2, pp. 196–200, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. H. Shi, H. Liu, and C. Y. Guo, “Study on the immune modulator of patients with ulcerative colitis,” Basic Research, vol. 1, no. 11, pp. 31–33, 2007. View at Google Scholar
  27. M. Bosani, S. Ardizzone, and G. B. Porro, “Biologic targeting in the treatment of inflammatory bowel diseases,” Biologics: Targets & Therapy, vol. 3, pp. 77–97, 2009. View at Google Scholar · View at Scopus
  28. S. Akira, K. Takeda, and T. Kaisho, “Toll-like receptors: critical proteins linking innate and acquired immunity,” Nature Immunology, vol. 2, no. 8, pp. 675–680, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. X. Liu, Y. W. Ding, and H. Lin, “Expression of TLR2, TLR4, TLR5 and TLR9 in Hp infected mice,” China Journal of Modern Medicine, vol. 22, no. 22, pp. 19–22, 2012. View at Google Scholar
  30. S. Sato, O. Takeuchi, T. Fujita, H. Tomizawa, K. Takeda, and S. Akira, “A variety of microbial components induce tolerance to lipopolysaccharide by differentially affecting MyD88-dependent and -independent pathways,” International Immunology, vol. 14, no. 7, pp. 783–791, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Jacinto, T. Hartung, C. McCall, and L. Li, “Lipopolysaccharide- and lipoteichoic acid-induced tolerance and cross-tolerance: distinct alterations in IL-1 receptor-associated kinase,” Journal of Immunology, vol. 168, no. 12, pp. 6136–6141, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. F. Schinzari, A. Armuzzi, B. de Pascalis et al., “Tumor necrosis factor-α antagonism improves endothelial dysfunction in patients with Crohn's disease,” Clinical Pharmacology and Therapeutics, vol. 83, no. 1, pp. 70–76, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Azuma, Y. J. Li, S. Abe et al., “Interferon-β inhibits bleomycin-induced lung fibrosis by decreasing transforming growth factor-β and thrombospondin,” American Journal of Respiratory Cell and Molecular Biology, vol. 32, no. 2, pp. 93–98, 2005. View at Publisher · View at Google Scholar
  34. M. H. G. Rep, R. Q. Hintzen, C. H. Polman, and R. A. W. van Lier, “Recombinant interferon-β blocks proliferation but enhances interleukin-10 secretion by activated human T-cells,” Journal of Neuroimmunology, vol. 67, no. 2, pp. 111–118, 1996. View at Publisher · View at Google Scholar · View at Scopus
  35. J. J. Kovarik, W. Tillinger, J. Hofer et al., “Impaired anti-inflammatory efficacy of n-butyrate in patients with IBD,” European Journal of Clinical Investigation, vol. 41, no. 3, pp. 291–298, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. Z. Y. Tian, L. H. Wang, X. A. Su et al., “Study on dendritic cells and IL-6, IL-12 in the patients with ulcerative colitis,” Chinese Journal of Gastroenterology and Hepatology, vol. 19, no. 11, pp. 1036–1038, 2010. View at Google Scholar
  37. N. C. Arbour, E. Lorenz, B. C. Schutte et al., “TLR4 mutations are associated with endotoxin hyporesponsiveness in humans,” Nature Genetics, vol. 25, no. 2, pp. 187–191, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. K. R. Engelhardt and B. Grimbacher, “IL-10 in humans: lessons from the gut, IL-10/IL-10 receptor deficiencies, and IL-10 polymorphisms,” in Interleukin-10 in Health and Disease, vol. 380 of Current Topics in Microbiology and Immunology, pp. 1–18, Springer, Berlin, Germany, 2014. View at Publisher · View at Google Scholar
  39. L. Zou, L. Wang, X. Gong, H. Zhao, A. Jiang, and S. Zheng, “The association between three promoter polymorphisms of IL-10 and inflammatory bowel diseases (IBD): a meta-analysis,” Autoimmunity, vol. 47, no. 1, pp. 27–39, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Shiotani, H. Kusunoki, Y. Kimura et al., “S100A expression and interleukin-10 polymorphisms are associated with ulcerative colitis and diarrhea predominant irritable bowel syndrome,” Digestive Diseases and Sciences, vol. 58, no. 8, pp. 2314–2323, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. D. S. Shouval, A. Biswas, J. A. Goettel et al., “Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function,” Immunity, vol. 40, no. 5, pp. 706–719, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. G. Fonseca-Camarillo, J. Furuzawa-Carballeda, L. Llorente, and J. K. Yamamoto-Furusho, “IL-10- and IL-20-expressing epithelial and inflammatory cells are increased in patients with ulcerative colitis,” Journal of Clinical Immunology, vol. 33, no. 3, pp. 640–648, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. P. J. Mannon, R. L. Hornung, Z. Yang et al., “Suppression of inflammation in ulcerative colitis by interferon-β-1a is accompanied by inhibition of IL-13 production,” Gut, vol. 60, no. 4, pp. 449–455, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. E. Musch, T. Andus, M. Malek, A. Chrissafidou, and M. Schulz, “Successful treatment of steroid refractory active ulcerative colitis with natural interferon-β—an open long-term trial,” Zeitschrift fur Gastroenterologie, vol. 45, no. 12, pp. 1235–1240, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. H. G. Wu, Z. Shi, Y. Zhu et al., “Clinical research for the herb-partition moxibustion treatment of ulcerative colitis,” Shanghai Journal of Acupuncture and Moxibustion, vol. 26, no. 4, pp. 3–4, 2007. View at Google Scholar
  46. E.-H. Zhou, H.-R. Liu, H.-G. Wu et al., “Down-regulation of protein and mRNA expression of IL-8 and ICAM-1 in colon tissue of ulcerative colitis patients by partition-herb moxibustion,” Digestive Diseases and Sciences, vol. 54, no. 10, pp. 2198–2206, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. X. M. Wang, Y. Lu, L. Y. Wu et al., “Moxibustion inhibits interleukin-12 and tumor necrosis factor alpha and modulates intestinal flora in rat with ulcerative colitis,” World Journal of Gastroenterology, vol. 18, no. 46, pp. 6826–6835, 2012. View at Google Scholar
  48. H. G. Wu, H. R. Liu, L. Y. Tan et al., “Electroacupuncture and moxibustion promote neutrophil apoptosis and improve ulcerative colitis in rats,” Digestive Diseases and Sciences, vol. 52, pp. 379–384, 2007. View at Google Scholar